Institutional Ownership
Pfizer Inc
CUSIP 717081103COMPFEQ1 2026
Latest EPS (Diluted)
$0.47
Q1 2026 · Mar 31, 2026
Latest Revenue
$14.45B
Reported quarter
Latest Net Income
$2.69B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.47 | $0.47 | $14.45B | $2.69B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $0.62 | $0.62 | $16.65B | $3.54B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $0.51 | $0.51 | $14.65B | $2.91B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $0.52 | $0.52 | $13.71B | $2.97B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $0.79 | $0.78 | $17.70B | $4.46B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $0.01 | $0.01 | $13.28B | $41.00M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $0.55 | $0.55 | $14.88B | $3.12B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $-0.42 | $-0.42 | $13.49B | -$2.38B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $0.41 | $0.41 | $13.01B | $2.33B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $0.98 | $0.97 | $18.49B | $5.54B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $1.54 | $1.51 | $22.64B | $8.61B | 10-Q |
| Jun 30, 2022 | Q2 2022 | $1.77 | $1.73 | $27.74B | $9.91B | 10-Q |